In addition, we found no variation in the binding intensity of E2f4 to metabolic target genes in TKO HCC (Supplementary Fig. 2g), suggesting that the amplification of E2f transcriptional response in TKO HCC does not primarily originate from decreased activity of repressor E2fs. The gene discussed is E2F4; the disease is hepatocellular carcinoma.